NCT02312687 - Long-Term Extension Study of KRN23 in Adult Subjects With X-Linked Hypophosphatemia (XLH) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 30, 2015

Primary Completion Date

November 30, 2018

Study Completion Date

November 30, 2018

Conditions

X-Linked Hypophosphatemia

Interventions

BIOLOGICAL

KRN23

solution for SC injection

Trial Locations (5)

Duke University, Durham

Indiana University Hospital, Indianapolis

Houston Methodist Reasearch Institute, Houston

University California San Francisco Hospital, San Francisco

Yale University School of Medicine, New Haven